Palbociclib enhances activin‐<scp>SMAD</scp>‐induced cytostasis in estrogen receptor‐positive breast cancer

Mayumi Harada(Tokyo Health Care University), Daizo Koinuma(The University of Tokyo), Takayuki Ozawa(Nagoya University), Mai Kobayashi(The University of Tokyo), Kohei Miyazono(The University of Tokyo), Masahiko Tanabe(The University of Tokyo), Masato Morikawa(The University of Tokyo), Yusuke Tamura(University of Tsukuba), Kei Takahashi(Howard Hughes Medical Institute), Keiichiro Tada(Nihon University), Yasuyuki Seto(Tokyo National Hospital)
Cancer Science
October 21, 2018
Cited by 21


Related Papers